Can anyone offer a plausible explanation as to why Acadia hasn't proceeded with the final stage trial in Fragile X when the trial results to date have been so positive?
Given that a successful trial and subsequent approval would generate considerable revenue to NEU, surely NEU has protected themselves against Acadia not proceeding in a timely manner?
I'm beyond confused - can someone help me?
Can anyone offer a plausible explanation as to why Acadia hasn't...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.27 |
Change
-0.270(2.15%) |
Mkt cap ! $1.522B | |||
| Open | High | Low | Value | Volume |
| $12.45 | $12.45 | $11.88 | $3.508M | 289.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 33 | $12.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.28 | 176 | 3 |
View Market Depth
| Last trade - 13.07pm 23/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |